Identifying chondroprotective diet-derived bioactives and investigating their synergism
RK Davidson, J Green, S Gardner, Y Bao, A Cassidy… - Scientific reports, 2018 - nature.com
Osteoarthritis (OA) is a multifactorial disease and nutrition is a modifiable factor that may
contribute to disease onset or progression. A detailed understanding of mechanisms …
contribute to disease onset or progression. A detailed understanding of mechanisms …
Nutraceuticals: potential for chondroprotection and molecular targeting of osteoarthritis
DJ Leong, M Choudhury, DM Hirsh, JA Hardin… - International journal of …, 2013 - mdpi.com
Osteoarthritis (OA) is a degenerative joint disease and a leading cause of adult disability.
There is no cure for OA, and no effective treatments which arrest or slow its progression …
There is no cure for OA, and no effective treatments which arrest or slow its progression …
Unraveling natural products' role in osteoarthritis management—An overview
GE Deligiannidou, RE Papadopoulos, C Kontogiorgis… - Antioxidants, 2020 - mdpi.com
The natural process of aging gradually causes changes in living organisms, leading to the
deterioration of organs, tissues, and cells. In the case of osteoarthritis (OA), the degradation …
deterioration of organs, tissues, and cells. In the case of osteoarthritis (OA), the degradation …
Nutraceutical activity in osteoarthritis biology: a focus on the nutrigenomic role
S D'Adamo, S Cetrullo, V Panichi, E Mariani… - Cells, 2020 - mdpi.com
Osteoarthritis (OA) is a disease associated to age or conditions that precipitate aging of
articular cartilage, a post-mitotic tissue that remains functional until the failure of major …
articular cartilage, a post-mitotic tissue that remains functional until the failure of major …
Punicalin alleviates TNF‐α‐and IL‐1β‐induced chondrocyte dysfunction and cartilage metabolism via mediating FOXO3 signaling axis
L Yang, C Fan, T Shu, S Wang - Journal of Food Biochemistry, 2021 - Wiley Online Library
Abstract Forkhead box O3 (FOXO3) transcription factor is involved in chondral homeostasis
of normal, aging and osteoarthritis (OA) cartilage. At present, we aimed to investigate …
of normal, aging and osteoarthritis (OA) cartilage. At present, we aimed to investigate …
Natural compounds: potential therapeutics for the inhibition of cartilage matrix degradation in osteoarthritis
Osteoarthritis (OA) is the most common degenerative joint disease characterized by
enzymatic degradation of the cartilage extracellular matrix (ECM) causing joint pain and …
enzymatic degradation of the cartilage extracellular matrix (ECM) causing joint pain and …
Effects of flavonoids on matrix metalloproteinase-13 expression of interleukin-1β–treated articular chondrocytes and their cellular mechanisms: inhibition of c-Fos/AP-1 …
H Lim, H Park, HP Kim - Journal of pharmacological sciences, 2011 - Elsevier
To identify the therapeutic potential for cartilage degradation and its action mechanisms, the
effects of naturally-occurring flavonoids on matrix metalloproteinase-13 (MMP-13) induction …
effects of naturally-occurring flavonoids on matrix metalloproteinase-13 (MMP-13) induction …
Achyranthoside D attenuates chondrocyte loss and inflammation in osteoarthritis via targeted regulation of Wnt3a
W Xie, S Qi, L Dou, L Wang, X Wang, R Bi, N Li… - Phytomedicine, 2023 - Elsevier
Abstract Background Achyranthes bidentata Blume (A. bidentata) is a common Chinese
herb used to treat osteoarthritis (OA). Achyranthoside D (Ach-D) is a glucuronide saponin …
herb used to treat osteoarthritis (OA). Achyranthoside D (Ach-D) is a glucuronide saponin …
The potential for dietary factors to prevent or treat osteoarthritis
JA Green, KL Hirst-Jones, RK Davidson… - Proceedings of the …, 2014 - cambridge.org
Osteoarthritis (OA) is a degenerative joint disease for which there are no disease-modifying
drugs. It is a leading cause of disability in the UK. Increasing age and obesity are both major …
drugs. It is a leading cause of disability in the UK. Increasing age and obesity are both major …
Curcumenol mitigates chondrocyte inflammation by inhibiting the NF‑κB and MAPK pathways, and ameliorates DMM‑induced OA in mice
X Yang, Y Zhou, Z Chen, C Chen… - International …, 2021 - spandidos-publications.com
At present, an increasing number of individuals are affected by osteoarthritis (OA), resulting
in a heavy socioeconomic burden. OA in knee joints is caused by the release of …
in a heavy socioeconomic burden. OA in knee joints is caused by the release of …